Reduce manufacturing costs with excipients designed for high productivity
IFF Pharma Solutions offers more than polymers designed for controlled release. We offer unique products to reduce manufacturing complexity to save you time and money. Designed morphology excipients, like METHOCEL™ DC2, can streamline matrix tablet production by bypassing costly wet granulation and drying steps. Moreover, our range of ethylcellulose based products, including water-based technologies and dry-powder coatings, allow you to tailor your barrier membrane coating system for optimal flexibility.
Controlled release beyond tablets
IFF controlled release technologies surpass conventional matrix tablets. Our expertise extends to formulating multiparticulate drug-delivery systems with barrier membrane coatings, osmotic pump tablets, gastro-retentive formulations and more. Our technical experts around the globe are ready to help you on your formulation journey.
Technology | Application | Recommended Products |
|---|---|---|
Multiparticles | Substrate | Avicel® PH spheres produced via extrusion spheronization |
Drug layering binder | METHOCEL™ E3, E5, E6 or VLV Premium | |
Modified release Solvent Based | ETHOCEL™ Std 4, 7, 10, 14 Premium | |
Water Based | Aquacoat® ECD-30, CPD-30 | |
Dry Powder | ETHOCEL™ HP | |
Coascervation | ETHOCEL™ Std 45, 100 Premium | |
Tableting cushioning compression aid | Avicel® PH 200, 200 LM Avicel® SMCC 90, 90 HD | |
Matrices | CR Matrix Former | METHOCEL™ K100 PRM LV, K4M PRM, K100M PRM, E4M PRM POLYOX™ N60K NF, 301 NF, Coagulant NF, 303 NF ETHOCEL™ STD PRM FP products Protanal® CR 8133 and 8233, Manucol® LKX |
Osmotic Pump Tablets | Push Layer Swelling Polymer | POLYOX™ 301 NF, Coagulant NF, 303 NF |
Drug Layer Drug Dispersant | POLYOX™ N10 NF, N80 NF |
*Examples only and not representative of a complete list of recommended products or benefits.
Learn more about how we can support your formulation.
Learn more about how we can support your formulation.
